{"blog": [], "keywords": [{"value": "Immune System", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Cancer", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Research", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Blood", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "June, Carl H", "name": "persons", "rank": "5", "is_major": "N"}, {"value": "Series", "name": "subject", "rank": "6", "is_major": "Y"}, {"value": "National Cancer Institute", "name": "organizations", "rank": "7", "is_major": "Y"}, {"value": "Sadelain, Michel", "name": "persons", "rank": "8", "is_major": "N"}, {"value": "Rosenberg, Steven A", "name": "persons", "rank": "9", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/08/02/health/cancer-cell-therapy-immune-system.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/08/01/science/01CANCER2-01/01CANCER2-01-thumbWide-v3.jpg", "legacy": {"wide": "images/2016/08/01/science/01CANCER2-01/01CANCER2-01-thumbWide-v3.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/08/01/science/01CANCER2-01/01CANCER2-01-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2016/08/01/science/01CANCER2-01/01CANCER2-01-articleLarge-v2.jpg", "xlargeheight": "399", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 399}, {"url": "images/2016/08/01/science/01CANCER2-01/01CANCER2-01-thumbStandard-v3.jpg", "legacy": {"thumbnail": "images/2016/08/01/science/01CANCER2-01/01CANCER2-01-thumbStandard-v3.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Health", "word_count": "4425", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer.", "pub_date": "2016-08-02T04:00:00+0000", "news_desk": "National", "headline": {"print_headline": "Setting Body\u2019s \u2018Serial Killers\u2019 Loose on Cancer", "main": "Setting the Body\u2019s \u2018Serial Killers\u2019 Loose on Cancer"}, "print_page": "1", "snippet": "After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer....", "_id": "579f967938f0d861602e19f0", "slideshow_credits": null, "abstract": "Group of researchers, including Dr Steven A Rosenberg, chief of surgery at National Cancer Institute, have been at forefront of intense pursuit of daring new treatment for cancer called cell therapy, which turbocharges immune system to fight cancer; versions of this therapy for limited number of blood cancers are nearing approval by federal regulators, and could reach market as early as 2017 (Series: Cell Wars)."}